Clinical trial
Efficacy of Clean Intermittent Self-catheterization in Combination With Anticholinergic Drugs for Treatment of Bladder Dysfunction in Multiple Sclerosis
NCT00913510 is registered in ClinicalTrials.gov with Wellspect HealthCare as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Clean Intermittent Self-catheterization in Combination With Anticholinergic Drugs for Treatment of Bladder Dysfunction in Multiple Sclerosis
- Lead sponsor
- Wellspect HealthCare
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- December 31, 2009
- Completion date
- May 31, 2012
- Enrollment
- 24 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
bladder dysfunction, multiple sclerosis